{"abstract": "The drugs for breast cancer and multiple myeloma will be given to patients in advanced stages of those diseases.", "web_url": "https://www.nytimes.com/2012/07/21/health/research/fda-approves-afinitor-and-kyprolis-for-breast-cancer-and-myeloma.html", "snippet": "The drugs for breast cancer and multiple myeloma will be given to patients in advanced stages of those diseases.", "lead_paragraph": "New drugs for breast cancer and multiple myeloma won approval from the Food and Drug Administration on Friday, expanding options for patients in advanced stages of those diseases. ", "print_section": "B", "print_page": "4", "source": "The New York Times", "multimedia": [], "headline": {"main": "F.D.A. Approves Drugs for Cancer and Myeloma", "kicker": null, "content_kicker": null, "print_headline": "F.D.A. Approves Drugs for Cancer and Myeloma", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Novartis AG", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Onyx Pharmaceuticals", "rank": 3, "major": "N"}, {"name": "subject", "value": "Breast Cancer", "rank": 4, "major": "N"}, {"name": "subject", "value": "Myeloma", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 6, "major": "N"}], "pub_date": "2012-07-21T00:58:29+0000", "document_type": "article", "news_desk": "Business", "section_name": "Health", "subsection_name": "Research", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/bda52f04-12da-549c-94eb-eb86aa122715", "word_count": 569, "uri": "nyt://article/bda52f04-12da-549c-94eb-eb86aa122715"}